EMBL-EBI | Chemical Biology Resources | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C18H23N5O3 |
| Net Charge | 0 |
| Average Mass | 357.414 |
| Monoisotopic Mass | 357.18009 |
| SMILES | [H][C@]12Cc3c(C(=O)N[C@H](CO)C(C)(C)C)nn(-c4c[n+]([O-])ccn4)c3[C@@]1([H])C2 |
| InChI | InChI=1S/C18H23N5O3/c1-18(2,3)13(9-24)20-17(25)15-12-7-10-6-11(10)16(12)23(21-15)14-8-22(26)5-4-19-14/h4-5,8,10-11,13,24H,6-7,9H2,1-3H3,(H,20,25)/t10-,11-,13+/m0/s1 |
| InChIKey | ACSQLTBPYZSGBA-GMXVVIOVSA-N |
| Roles Classification |
|---|
| Biological Role: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. |
| Applications: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. antispasmodic drug A drug that suppresses spasms. These are usually caused by smooth muscle contraction, especially in tubular organs. The effect is to prevent spasms of the stomach, intestine or urinary bladder. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| olorinab (CHEBI:756627) has role analgesic (CHEBI:35480) |
| olorinab (CHEBI:756627) has role antispasmodic drug (CHEBI:53784) |
| olorinab (CHEBI:756627) is a aromatic amide (CHEBI:62733) |
| olorinab (CHEBI:756627) is a heteroarene (CHEBI:33833) |
| INN | Source |
|---|---|
| olorinab | WHO MedNet |
| Synonyms | Source |
|---|---|
| APD-371 | ChEMBL |
| APD371 | ChEMBL |
| Citations |
|---|